True or False: Neostigmine is considered an intermediate-acting drug.

Neostigmine is classified as an intermediate-acting drug because it functions as an acetylcholinesterase inhibitor, effectively prolonging the action of acetylcholine at neuromuscular junctions. This characteristic allows it to be used in the management of conditions such as myasthenia gravis and to reverse the effects of muscle relaxants after surgery.

The duration of action for neostigmine is typically several hours, which reinforces its classification as intermediate-acting compared to other cholinergic agents. Short-acting agents would have a much faster onset and duration, while long-acting agents would maintain their effects for a significantly longer period. Therefore, the assertion that neostigmine is an intermediate-acting drug is accurate.